Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.120
+0.090 (4.43%)
At close: Jan 27, 2026, 4:00 PM EST
2.132
+0.012 (0.58%)
Pre-market: Jan 28, 2026, 9:11 AM EST
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $102.41 million as of January 28, 2026. Its market cap has decreased by -24.78% in one year.
Market Cap
102.41M
Enterprise Value
-3.67M
1-Year Change
-24.78%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $102.41M, a decrease of -51.83%. That is a compound annual growth rate of -2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 102.41M | 7.07% |
| Dec 31, 2025 | 95.65M | -15.76% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 106.88M |
| Inovio Pharmaceuticals | 105.12M |
| Champions Oncology | 104.59M |
| Anixa Biosciences | 102.80M |
| Pyxis Oncology | 102.42M |
| Dogwood Therapeutics | 101.70M |
| MindWalk Holdings | 101.55M |
| Korro Bio | 101.33M |